Next, we developed a mouse orthotopic model of ovarian cancer to investigate the potential therapeutic value of IDO1.Two weeks after OC orthotopic implantation, the mice were treated with or without 1- Methyl-DL-tryptophan for 6 weeks. Here, IDO1 is linked to ovarian carcinoma.